Insider Selling: ICU Medical Inc. (ICUI) VP Sells $230,814.87 in Stock
ICU Medical Inc. (NASDAQ:ICUI) VP Virginia Ruth Sanzone sold 1,903 shares of the firm’s stock in a transaction dated Monday, September 12th. The shares were sold at an average price of $121.29, for a total value of $230,814.87. Following the sale, the vice president now owns 3,049 shares in the company, valued at approximately $369,813.21. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
ICU Medical Inc. (NASDAQ:ICUI) opened at 122.35 on Tuesday. The stock has a market cap of $1.97 billion, a P/E ratio of 36.44 and a beta of 0.49. The stock has a 50 day moving average price of $123.10 and a 200 day moving average price of $109.28. ICU Medical Inc. has a 12-month low of $85.56 and a 12-month high of $128.93.
ICU Medical (NASDAQ:ICUI) last issued its earnings results on Monday, August 8th. The company reported $1.15 EPS for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.10. The business had revenue of $96.70 million for the quarter, compared to analyst estimates of $89.66 million. ICU Medical had a net margin of 14.94% and a return on equity of 10.33%. The company’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same period last year, the company posted $0.97 earnings per share. On average, analysts forecast that ICU Medical Inc. will post $4.54 earnings per share for the current fiscal year.
A number of equities research analysts have weighed in on the company. Piper Jaffray Cos. restated a “neutral” rating and set a $119.00 price target (up previously from $115.00) on shares of ICU Medical in a research report on Thursday, August 11th. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price objective on the stock in a report on Friday, August 12th.
Several institutional investors have recently modified their holdings of ICUI. Mason Street Advisors LLC acquired a new position in shares of ICU Medical during the second quarter valued at about $319,000. Royal Bank of Canada raised its position in shares of ICU Medical by 57.2% in the second quarter. Royal Bank of Canada now owns 207,226 shares of the company’s stock valued at $23,365,000 after buying an additional 75,396 shares during the last quarter. Schwab Charles Investment Management Inc. raised its position in shares of ICU Medical by 4.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 48,889 shares of the company’s stock valued at $5,513,000 after buying an additional 2,004 shares during the last quarter. Stifel Financial Corp raised its position in shares of ICU Medical by 10.9% in the second quarter. Stifel Financial Corp now owns 67,649 shares of the company’s stock valued at $7,627,000 after buying an additional 6,656 shares during the last quarter. Finally, Amalgamated Bank acquired a new position in shares of ICU Medical during the second quarter valued at about $214,000. 89.50% of the stock is currently owned by institutional investors and hedge funds.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.